Strong global recognition of Lundbeck’s reputation

In a worldwide survey, Lundbeck is ranked number 2 out of 46 pharma companies when it comes to our reputation among patient groups working with us.

Today, PatientView has published their annual survey ‘The Corporate Reputation of Pharma. Based on feedback from 1,330 patient groups, 46 pharma companies were surveyed for their corporate reputation based on 12 different indicators. Overall, Lundbeck made the top tier and specifically excelled in patient centricity, patient information, integrity and quality of patient group relationships.

Read the release from PatientView

Collaboration with patient groups is pivotal

There is a lot to be proud of in this global survey, which recognizes our extensive efforts to engage with patient groups on a local and global level. The survey underlines our engagement in mutually meaningful relationships for the patient groups and Lundbeck. Strong partnerships with patient groups all around the world is key in our commitment to people living with psychiatric and neurological disorders,” says Interim CEO & CFO, Anders Götzsche.

Patient groups’ loyalty to Lundbeck is best in class

For the first time, PatientView assessed the patient groups loyalty to the companies, measured by the Net Promotor Score. A score for how likely they are to promote a company. Lundbeck excelled on this parameter and came out best in class with the highest Net Promoter Score among the 46 pharma companies.

                                                Figure: Calculation of the Net Promotor Score

Snapshots of Lundbeck’s ranking and profile of the respondents

In 2017, the twelve indicators of corporate reputation were:
1. Patient centricity 5i. Transparency: pricing [new] 7. Quality of relationships with patient groups
2. Patient information 5ii. Transparency: clinical-trial data [new] 8. 'Beyond the pill' [new]
3. Patient safety 5iii. Transparency: funding of stakeholders 9i. Engaging patients in research [new]
4. High-quality products 6. Integrity 9ii. Engaging patients in development [new]

Results of the survey

  • Lundbeck is ranked 7 out of 46 pharma companies among patient groups familiar with us (8th in 2016)
  • Number of groups familiar with Lundbeck: 193
  • Number of groups working with Lundbeck: 53
  • Excelled in patient centricity, patient information, integrity and quality of patient group relationships
  • Best in class on the newly included Net Promoter Score
  • Largest familiarity with Lundbeck among patient groups is by far in the US

About PatientView

PatientView is a UK-based research, publishing, and consultancy group, created out of a belief that the views of patients should be considered in all important healthcare decisions (whether a new healthcare product is being developed, or whether a government is instituting changes to a health system). The organisation was formed in response to the emerging powerful new global patient movement. PatientView has worked to build bridges worldwide with the health NGOs that comprise the patient movement—to help define and support one of the most important factors changing healthcare in the 21st century.

Cookie Policy
You have chosen to leave Lundbeck does not have any responsibility for the content provided by other websites. Click "OK" to continue or "Cancel" to remain on